Facts about EoE
Learn about the basics of EoE. Below you will find a quick overview about EoE and links to publications if you want to go even deeper. These resources explain what Eosinophilic Esophagitis (EoE) is, its common symptoms, and how it may affect daily life. You will also find information about possible causes, diagnosis, and current approaches to management and treatment.
The contents of this page will be available in May 2026.
1. EoE Is a Chronic Immune-Mediated Disease
EoE is a chronic inflammatory condition of the esophagus driven by an abnormal immune response, primarily involving eosinophils (a type of white blood cell).
Eosinophilic esophagitis (EoE) is a chronic immune-mediated inflammatory disease of the esophagus characterized by infiltration of eosinophils into the esophageal epithelium. The disease is driven primarily by type 2 helper T-cell (Th2) immune responses, involving cytokines such as IL4, IL-5, IL-13, and eotaxin-3, which recruit eosinophils into the esophageal tissue. Persistent inflammation leads to epithelial barrier dysfunction and tissue remodeling.
Currently, eosinophilic esophagitis (EoE) is the second most common inflammatory disorder of the esophagus after gastroesophageal reflux disease and represents the most frequent underlying cause of bolus obstruction. The disease often follows a chronic relapsing course and requires long-term management.
Learn more
2. EoE Is Triggered Mainly by Food Antigens
In most patients, EoE is caused by an immune reaction to specific foods — commonly milk, wheat, eggs, soy, nuts, and seafood.
In most patients, EoE is triggered by food antigens that stimulate an immune response in the esophageal mucosa. The most frequently implicated foods are:
- Cow’s milk
- Wheat
- Eggs
- Soy
- Peanuts/tree nuts
- Fish or shellfish
These foods constitute the basis of the six-food elimination diet (SFED), which has been shown to induce histologic remission in approximately 60–70% of patients. In contrast to classical IgE-mediated food allergies, eosinophilic esophagitis (EoE) frequently involves both IgE- and non-IgE-mediated immune pathways.
Learn more
3. An EoE Diagnosis Requires Endoscopic Biopsy
EoE cannot be diagnosed by symptoms alone. It requires an upper endoscopy with at least six biopsies showing ≥15 eosinophils per high-power field in esophageal tissue.
The gold standard for diagnosing EoE is a combination of clinical symptoms and histologic findings on esophageal biopsy. Current guidelines recommend:
- Upper endoscopy with at least 6 biopsies taken from different esophageal locations
- Histologic threshold of ≥15 eosinophils per high-power field (eos/hpf)
- Exclusion of other causes of esophageal eosinophilia
Endoscopic findings often include rings (trachealization), furrows, white plaques/exudates, and strictures, but histology is required for confirmation.
Learn more
4. EoE Symptoms Differ by Age
Clinical presentation varies significantly across age groups.
- Infants/children: feeding difficulty, vomiting, failure to thrive
- Adolescents/adults: difficulty swallowing (dysphagia), food impaction
Infants and young children
- Feeding intolerance
- Vomiting
- Abdominal pain
- Food refusal
- Failure to thrive
Adolescents and adults
- Dysphagia (difficulty swallowing)
- Food impaction
- Chest discomfort
- Refractory reflux symptoms
These differences likely reflect behavioral adaptation and disease progression, as chronic inflammation can gradually lead to fibrosis and strictures in older patients.
Learn more
5. EoE is Increasing in Prevalence
The incidence of EoE has risen significantly over the past two decades, especially in Western countries. Current studies suggest about 1 in 700 individuals in the U.S. population is affected.
EoE has transitioned from a rare disease to one that is increasingly recognized worldwide. Studies show:
- A 5-fold increase in prevalence since 2009
- Estimated prevalence of about 1 in 700 individuals in the United States
The increase is likely due to both true epidemiologic growth and improved recognition and diagnosis.
Learn more
6. EoE is More Common in Males
EoE occurs about 3–4 times more frequently in males than females.
EoE shows a strong male predominance, with studies consistently reporting a 3–4:1 male-to-female ratio. The reasons are not fully understood but may involve:
- Genetic susceptibility
- Sex-related immune differences
- Environmental factors
Several susceptibility genes linked to EoE include TSLP and CAPN14, both associated with epithelial barrier function and allergic inflammation.
Learn more
7. EoE is Associated With Other Allergic Diseases
Many patients with EoE have coexisting atopic conditions such as asthma, allergic rhinitis, atopic eczema, or food allergies.
A large proportion of EoE patients have coexisting atopic conditions, including:
- Allergic Asthma
- Allergic rhinitis
- Atopic dermatitis
- IgE-mediated food allergies
Studies suggest that 60–80% of patients with EoE have at least one allergic disease, highlighting the shared type-2 inflammatory pathway underlying these conditions.
Learn more
8. Chronic Inflammation Can Cause Fibrosis
Untreated EoE can lead to esophageal narrowing, strictures, and rings due to long-term tissue remodeling and fibrosis.
Long-standing untreated EoE leads to tissue remodeling of the esophagus, including:
- Subepithelial fibrosis
- Esophageal rings
- Narrowing and strictures
This progression represents the transition from inflammatory to fibrostenotic disease, which increases the risk of food impaction and dysphagia.
Early treatment is therefore important to prevent structural complications.
Learn more
9. EoE Treatment Includes the three Ds
EoE treatment includes:
- Diets (e.g. elimination)
- Drugs (swallowed topical corticosteroids, PPI and Biologics)
- Dilation (endoscopic intervention)
Management typically focuses on reducing inflammation and preventing structural damage through three main strategies:
- Diet
- Empiric elimination diets (e.g., six-food elimination diet)
- Targeted elimination based on allergy testing
- Elemental diets in severe cases
- Drugs
- Proton pump inhibitors (PPIs)
- Swallowed topical corticosteroids (e.g., budesonide, fluticasone)
- Biologic therapies targeting type-2 inflammation (e.g., dupilumab)
- Dilation
- Endoscopic dilation for strictures and narrowing
Learn more
10. EoE Requires Long-Term Management
EoE is a chronic condition that usually requires ongoing treatment and monitoring. Symptoms may improve with therapy, but inflammation often returns if treatment is stopped.
EoE is a chronic relapsing disease, meaning inflammation typically recurs if treatment is discontinued. Studies demonstrate that:
- Histologic relapse occurs in most patients after stopping therapy.
- Long-term therapy is often needed to maintain remission and prevent fibrosis.
Monitoring may involve repeat endoscopy with biopsies, as symptoms alone do not reliably reflect disease activity.
Learn more